Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome: A Family Report
Shira London(Emek Medical Center), Yardena Tenenbaum-Rakover(Technion – Israel Institute of Technology), Ronen Spiegel(Technion – Israel Institute of Technology), Dong Li(Children's Hospital of Philadelphia), Rephael Halevy(Emek Medical Center), Asaf Lebel(Technion – Israel Institute of Technology), Michael A. Levine(Children's Hospital of Philadelphia)
Cited by 3
Related Papers
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
|Proceedings of the National Academy of Sciences|2004|745
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
|Blood|2008|345
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
|The American Journal of Human Genetics|2013|206
GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers
|The American Journal of Human Genetics|2016|183
Autism-Associated Mutations in ProSAP2/Shank3 Impair Synaptic Transmission and Neurexin–Neuroligin-Mediated Transsynaptic Signaling
|Journal of Neuroscience|2012|180